LAPIX Therapeutics Inc. is a Boston, MA-based company in the biopharma sector, focused on developing novel, orally bioavailable immune system restoration therapies, including immune tolerance restoration therapy for autoimmune diseases, immune tolerance induction therapies for gene therapy and enzyme replacement therapy, and immune function restoration therapies for oncology.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 451 D St,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.lapix.com
- Keywords
- Immuno-oncology, Tolerance Induction, Auto-immune Disorders, Gene Therapy, Enzyme Replacement Therapy.
- HQ
- Boston, Massachusetts
Lapix Therapeutics Questions
Lapix Therapeutics's website is http://www.lapix.com
Lapix Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lapix-therapeutics
Lapix Therapeutics has
13 employees.
View email and phone details for 13
employees at Lapix Therapeutics.
Lapix Therapeutics's industry is
Pharmaceutical Manufacturing
Lapix Therapeutics's top competitors are
Mytide Therapeutics,
Paulex Bio,
Tolerance Bio,
Rubedo Life Sciences,
The Bernstein Companies,
Elektrofi,
Praetorian Bio,
Vertex Pharmaceuticals,
Nimbus Therapeutics,
Avalor Therapeutics.
Lapix Therapeutics's categories are Pharmaceutical Manufacturing
Lapix Therapeutics's founding year is 2019
